Whole-Brain Radiotherapy Combined With Anlotinib for Multiple Brain Metastases From Non-small Cell Lung Cancer Without Targetable Driver Mutation: A Single-Arm, Phase II Study

BACKGROUND: Existing evidence demonstrates that radiotherapy and antiangiogenic drugs have synergistic antitumour effects and may be a promising treatment option for patients with solid tumour. Thus, we performed a phase II trial to evaluate the efficacy and safety of whole-brain radiotherapy (WBRT)...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jianjiang, Xu, Jun, Ye, Wanli, Zhong, Wangyan, Zhang, Xiaoyu, Mao, Jiwei, Wu, Dongping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891900/
https://www.ncbi.nlm.nih.gov/pubmed/35250325
http://dx.doi.org/10.1177/11795549221079185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8891900/
https://www.ncbi.nlm.nih.gov/pubmed/35250325
http://dx.doi.org/10.1177/11795549221079185

Ejemplares similares